⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2771972 | 1.00 | TTR (0.36) | — | |
| SCHEMBL9051405 | 1.00 | TTR (0.36) | — | |
| Methane SCHEMBL12477494 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL1434836 | 0.96 | TTR (0.33) | — | |
| SCHEMBL14841784 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL4491180 | 0.96 | TTR (0.33) | — | |
| Iodide SCHEMBL3075479 | 0.96 | — | — | |
| SCHEMBL9760083 | 0.96 | TTR (0.33) | — | |
| Bromide SCHEMBL5069293 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL17919 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8587 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036730-A | Gαq/11 protein inhibitor with purine skeleton, and preparation method and application thereof | 中山大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122010986-A | Preparation method of near infrared luminous halide monocrystal scintillator | 北京工业大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260109691-A1 | PROCESS FOR MANUFACTURING ALOGABAT | HOFFMANN-LA ROCHE INC. (US) | 2026-04-23 | — | — | US | claimed |
| EP-4127157-B1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | ENCODIA INC (US) | 2026-02-11 | — | — | EP | claimed |
| CN-120092001-A | Method for producing ALOGABAT | 豪夫迈·罗氏有限公司 | 2025-06-03 | — | — | CN | claimed |
| US-20250154198-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | ZEALAND PHARMA A/S (DK) | 2025-05-15 | — | — | US | claimed |
| CN-119735600-A | 3-Ureido substituted thieno [2,3-b ] pyridine compound and preparation method and application thereof | 华东师范大学 | 2025-04-01 | — | — | CN | claimed |
| CN-119661508-A | Preparation method and application of dual-mechanism ERK inhibitor | 苏州健雄职业技术学院 | 2025-03-21 | — | — | CN | claimed |
| US-20250092026-A1 | METHOD FOR PREPARING BENZOFURAN DERIVATIVE | JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) | 2025-03-20 | — | — | US | claimed |
| CN-114761404-B | Substituted bicyclic heteroaryl compounds | 百时美施贵宝公司 | 2025-02-21 | — | — | CN | claimed |
| WO-2003027102-A1 | 3-(ARYLAMINO)METHYLENE-1, 3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS | ALLERGAN, INC. (US) | 2003-04-03 | — | — | WO | claimed |
| US-20030004359-A1 | Processes for producing tetrahydropyranyl-4-sulfonates and 4-aminotetrahydropyran compound | UBE INDUSTRIES, LTD. (JP) | 2003-01-02 | — | — | US | claimed |
| WO-2002098850-A2 | CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2002-12-12 | — | — | WO | claimed |
| US-20020188018-A1 | 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta | GONG LEYI (US) | 2002-12-12 | — | — | US | claimed |
| US-6479490-B2 | TREATMENT OF DISEASES CHARACTERIZED BY EXCESS TH2 CYTOKINES AND/ OR AN EXCESS IGE PRODUCTION. | SYNTEX (U.S.A.) LLC | 2002-11-12 | — | — | US | claimed |
| EP-1247807-A1 | PROCESSES FOR PRODUCING TETRAHYDROPYRANYL-4-SULFONATE AND 4-AMINOTETRAHYDROPYRAN COMPOUND | Ube Industries, Ltd. (JP) | 2002-10-09 | — | — | EP | claimed |
| WO-2002036555-A1 | SULFAMIDES AS GAMMA-SECRETASE INHIBITORS | MERCK SHARP & DOHME LIMITED (GB) | 2002-05-10 | — | — | WO | claimed |
| US-20020052397-A1 | 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta | SYNTEX (U.S.A.) LLC | 2002-05-02 | — | — | US | claimed |
| WO-2001070232-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-09-27 | — | — | WO | claimed |
| US-5821240-A | ENZYME INHIBITORS, SIGNAL INHIBITORS FOR ANTIINFLAMMATORY AGENTS, ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS AND HORMONE INHIBITORS | DR. KARL THOMAE GMBH (DE) | 1998-10-13 | — | — | US | claimed |